XML 39 R9.htm IDEA: XBRL DOCUMENT
v2.4.0.8

ACQUISITIONS OF BUSINESSES | 6 Months Ended
--- | ---
Jun. 30, 2013
Text Block [Abstract] |
ACQUISITIONS OF BUSINESSES | 3. ACQUISITIONS OF BUSINESSES The purchase price for the 72% interest in the February 2013 Acquisition was $4.3 million in cash and $400,000 in a seller note, that is payable in two principal installments totaling $200,000 each, plus accrued interest, in February 2014 and 2015. The purchase price for the 50% interest in the April 2013 Acquisition was $2.4 million in cash and $200,000 in a seller note, that is payable in two principal installments totaling $100,000 each, plus accrued interest, in April of 2014 and 2015. The purchase price for the 80% interest in the May 2013 Acquisition was $3.6 million in cash and $200,000 in a seller note, that is payable in two principal installments totaling $100,000 each, plus accrued interest, in May of 2014 and 2015. On February 1, 2013, through a subsidiary, the Company acquired a 100% interest in a clinic for $5,000 and on June 1, 2013, through another subsidiary, the Company acquired a 100% interest in a clinic for $95,000. The purchase prices have been preliminarily allocated as follows (in thousands):
Cash paid, net of cash acquired |  | $ | 9,998 |
Seller notes |  |  | 800 |
Total consideration |  | $ | 10,798 |
Estimated fair value of net tangible assets acquired: |  |  |  |
Total current assets |  | $ | 1,349 |
Total non-current assets |  |  | 719 |
Total liabilities |  |  | (242 | )
Net tangible assets acquired |  |  | 1,826 |
Goodwill |  |  | 14,400 |
Fair value of noncontrolling interest |  |  | (5,428 | )
|  | $ | 10,798 |
The consideration for each transaction was agreed upon through arm’s length negotiations. Funding for the cash portion of the purchase price was derived from proceeds from the Company’s revolving credit facility. The results of operations of these acquisitions have been included in the Company’s consolidated financial statements since acquired. Because these acquisitions occurred during the six months ended June 30, 2013, the purchase price plus the fair value of the non-controlling interest was allocated to the fair value of the assets acquired and liabilities assumed based on the preliminary estimates of the fair values at the acquisition date, with the amount exceeding the estimated fair values being recorded as goodwill. The Company is in the process of completing its formal valuation analysis to identify and determine the fair value of tangible and intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the preliminary estimates used at June 30, 2013 based on additional information obtained. Changes in the estimated valuation of the tangible and intangible assets acquired and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill. On May 22, 2012, the Company purchased a 70% interest in a 7 clinic group (“May 2012 Acquisition”). The purchase price for the 70% interest in the May 2012 Acquisition was $6,090,000 in cash and $250,000 in seller notes, that are payable in two principal installments totaling $125,000 each, plus any accrued interest, in May 2013 and 2014. The seller notes accrue interest at 3.25% per annum. For the Company, 70% of the goodwill for the May 2012 Acquisition is tax deductible. During the quarter ended March 31, 2013, the Company determined that the amounts attributable to intangible assets other than goodwill are as follows: tradenames - $1,300,000; referral relationships - $800,000; and non competition agreement - $240,000. The value assigned to referral relationships and the non competion agreements will be amortized over the related expected lives which are estimated to be 12 and six years, respectively. In addition to the May 2012 Acquisition, in 2012, the Company, through its subsidiaries, purchased 7 outpatient therapy practices in 7 transactions for aggregate cash consideration of $1,938,000 and, in one transaction, a $100,000 note payable. The purchase prices were allocated $43,000 to current assets, $213,000 to non-current assets, $25,000 to non competition agreements, $57,000 to referral relationships and $1,883,000 to goodwill. The purchase prices for the acquisitions in 2012 have been allocated as follows (in thousands):
Cash paid, net of cash acquired |  | $ | 7,929 |
Seller notes |  |  | 350 |
Total consideration |  | $ | 8,279 |
Estimated fair value of net tangible assets acquired: |  |  |  |
Total current assets |  | $ | 363 |
Total non-current assets |  |  | 478 |
Total liabilities |  |  | (290 | )
Net tangible assets acquired |  | $ | 551 |
Tradenames |  |  | 1,300 |
Referral relationships |  |  | 857 |
Non competition agreements |  |  | 265 |
Goodwill |  |  | 8,198 |
Fair value of noncontrolling interest |  |  | (2,892 | )
|  | $ | 8,279 |
The purchase price plus the fair value of the non-controlling interest for the 2012 acquisitions was allocated to the fair value of the assets acquired and liabilities assumed based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill. Unaudited proforma consolidated financial information for acquisitions occurring in 2013 and 2012 have not been included as the results were not material to current operations.

X
- Details
Name: | us-gaap_TextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Acquisition Of Business + References No definition available. + Details
Name: | usph_AcquisitionOfBusinessTextBlock
Namespace Prefix: | usph_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration